Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ProBion Daily
- Development stage
- Unknown
- Lead developer
- Wasa Medicals
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
ProBion Daily is a probiotic dietary supplement developed by Wasa Medicals AB, designed to support gut microbiome balance and digestive health. The formulation contains a combination of five live bacterial strains—*Lactobacillus plantarum*, *Lactobacillus acidophilus*, *Lactobacillus paracasei*, *Lactobacillus bulgaricus*, and *Bifidobacterium lactis*—delivering 6 billion CFU per tablet, supplemented with the prebiotic inulin. The product utilizes the proprietary PLC (Prolongation of Life Concept) Matrix technology, a low-compression freeze-drying process that protects the viability of the probiotics and enables a controlled release over 180 minutes within the gastrointestinal tract. It is marketed for individuals with normal or fluctuating digestion and is free from common allergens, including dairy, soy, and gluten.
- Brand names
- ProBion Daily
Beyond the preview
Go deeper on ProBion Daily.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ProBion Daily.